We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+16.47%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.6B
AUM Growth
+$842M
Cap. Flow
-$440M
Cap. Flow %
-4.14%
Top 10 Hldgs %
16.26%
Holding
2,304
New
726
Increased
425
Reduced
494
Closed
615

Top Buys

Rank Stock Value
1
MCD icon
McDonald's
MCD
+$240M
2
TMO icon
Thermo Fisher Scientific
TMO
+$151M
3
BSX icon
Boston Scientific
BSX
+$121M
4
AMZN icon
Amazon
AMZN
+$104M
5
TRU icon
TransUnion
TRU
+$81M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 22.87%
2 Healthcare 20.58%
3 Financials 10.9%
4 Technology 10.13%
5 Industrials 8.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MPT
1376
Medical Properties Trust
MPT
$2.89B
$148K ﹤0.01%
+8,006
New +$143K
LBY
1377
DELISTED
Libbey, Inc.
LBY
$147K ﹤0.01%
+51,704
New +$222K
EPM icon
1378
Evolution Petroleum
EPM
$137M
$146K ﹤0.01%
+21,701
New +$158K
ARES icon
1379
Ares Management
ARES
$28.5B
$145K ﹤0.01%
+6,269
New +$137K
SXI icon
1380
Standex International
SXI
$3.68B
$145K ﹤0.01%
+1,982
New +$150K
AUB icon
1381
Atlantic Union Bankshares
AUB
$5.99B
$144K ﹤0.01%
4,458
-85,251
-95% -$2.84M
ILF icon
1382
iShares Latin America 40 ETF
ILF
$3.77B
$144K ﹤0.01%
+4,322
New +$147K
SLM icon
1383
SLM Corp
SLM
$4.57B
$144K ﹤0.01%
14,544
-486,248
-97% -$5.03M
ACIU icon
1384
AC Immune
ACIU
$227M
$143K ﹤0.01%
28,347
-707,555
-96% -$4.5M
CHDN icon
1385
Churchill Downs
CHDN
$6.03B
$143K ﹤0.01%
3,176
-78,568
-96% -$3.51M
JELD icon
1386
JELD-WEN Holding
JELD
$94.8M
$143K ﹤0.01%
+8,090
New +$146K
KBWB icon
1387
Invesco KBW Bank ETF
KBWB
$6.88B
$141K ﹤0.01%
+2,924
New +$145K
MRSN
1388
DELISTED
Mersana Therapeutics
MRSN
$141K ﹤0.01%
+1,070
New +$135K
KWEB icon
1389
KraneShares CSI China Internet ETF
KWEB
$5.2B
$140K ﹤0.01%
2,964
-14,519
-83% -$637K
EVOK
1390
DELISTED
Evoke Pharma
EVOK
$139K ﹤0.01%
+642
New +$219K
LBRT icon
1391
Liberty Energy
LBRT
$2.83B
$139K ﹤0.01%
9,050
+4,425
+96% +$67.8K
CVLY
1392
DELISTED
Codorus Valley Bancorp Inc
CVLY
$139K ﹤0.01%
6,851
+5,396
+371% +$115K
CMS icon
1393
CMS Energy
CMS
$23.1B
$137K ﹤0.01%
+2,467
New +$130K
AMAL icon
1394
Amalgamated Financial
AMAL
$1.48B
$135K ﹤0.01%
+8,628
New +$155K
ITA icon
1395
iShares US Aerospace & Defense ETF
ITA
$14.2B
$134K ﹤0.01%
+1,340
New +$131K
PFIE
1396
DELISTED
Profire Energy, Inc
PFIE
$134K ﹤0.01%
+74,628
New +$132K
PE
1397
DELISTED
PARSLEY ENERGY INC
PE
$134K ﹤0.01%
+6,957
New +$128K
BT
1398
DELISTED
BT Group plc (ADR)
BT
$133K ﹤0.01%
+8,977
New +$134K
WSR
1399
DELISTED
Whitestone REIT
WSR
$132K ﹤0.01%
11,004
-141,010
-93% -$1.86M
ONEQ icon
1400
Fidelity Nasdaq Composite Index ETF
ONEQ
$10.2B
$131K ﹤0.01%
+4,330
New +$125K

Similar funds

Marshall Wace's Q1 2019 Portfolio in Review

As of Q1 2019, Marshall Wace held 2,304 positions worth $10.6B, up 8.6% from $9.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace withdrew a net $440M in Q1 2019, closing 615 positions and reducing 494 holdings. Its most notable exit was Shire pic, an estimated $166M position sold in full.

By sector, the portfolio is most concentrated in Consumer Discretionary at 23% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Marshall Wace opened a new position in TransUnion worth $87.4M.

  • Marshall Wace's largest Q1 2019 buy was TransUnion: 1,307,679 shares worth $87.4M.
  • Marshall Wace added most to McDonald's in Q1 2019, an estimated $240M increase.
  • Marshall Wace's biggest Q1 2019 reduction was Alphabet (Google) Class A, cutting an estimated $132M.
  • Marshall Wace fully exited Shire pic in Q1 2019, selling an estimated $166M.
  • Marshall Wace's ten largest holdings make up 16% of its $10.6B portfolio in Q1 2019.
  • Marshall Wace opened 726 new positions and closed 615 in Q1 2019.
  • Marshall Wace's portfolio value rose 8.6% quarter-over-quarter to $10.6B.

Based on Marshall Wace's 13F filing for Q1 2019, filed 14 May 2019.